Attendee Profile

By Geography:

Favourable government incentives, advanced infrastructure, talented pool of clinical researchers and scientists enable more and more Korean biopharma companies to jumpstart quickly in the booming biologics industry in Asia. Korea is also becoming an important launching pad for companies to expand into the regional emerging markets. Such vibrant biologics landscape is attracting the interests of developed countries as well as new entrants to foster closer research ties and commercial collaborations with Korean biopharma companies.

By Industry:

The biologics industry involves a complex picture of stakeholders. Each segment of stakeholders is characterized by its unique objectives, business activities and milestone achievements. Understanding how the dynamics of stakeholder’s interests and goals will help organization to move along the value chain effectively. Such understanding helps to create synergy opportunities, to forge collaboration and to enhance intellectual exchange, and at the end of the day, achieving economy of scale, effective cost management and better market positioning.

By Job Title:

Ensuring treatment efficacy, high product quality and consistent production are high priorities on biologic players’ agenda who wants to navigate through the regulatory challenges and to be the first to market. Understanding the synchronized interplay of different job activities is necessary in ensuring the process from biologic drug development to market launch transit seamlessly. Such understanding reduces costs and development risk. One department would not function effectively without understanding the roles of other departments.

Gold Sponsor

Gold Sponsor

Tech Showcase

Tech Showcase

Exhibitors

Exhibitors